Correlation Between Stoke Therapeutics and Alvotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Alvotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Alvotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Alvotech, you can compare the effects of market volatilities on Stoke Therapeutics and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Alvotech.

Diversification Opportunities for Stoke Therapeutics and Alvotech

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Stoke and Alvotech is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Alvotech go up and down completely randomly.

Pair Corralation between Stoke Therapeutics and Alvotech

Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 2.66 times more return on investment than Alvotech. However, Stoke Therapeutics is 2.66 times more volatile than Alvotech. It trades about 0.1 of its potential returns per unit of risk. Alvotech is currently generating about 0.05 per unit of risk. If you would invest  379.00  in Stoke Therapeutics on August 26, 2024 and sell it today you would earn a total of  764.00  from holding Stoke Therapeutics or generate 201.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Stoke Therapeutics  vs.  Alvotech

 Performance 
       Timeline  
Stoke Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Alvotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Alvotech is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Stoke Therapeutics and Alvotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stoke Therapeutics and Alvotech

The main advantage of trading using opposite Stoke Therapeutics and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.
The idea behind Stoke Therapeutics and Alvotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings